플러스100%마이너스

통합검색
닫기

KMCRIC 챗봇에게

질문하기!

한의약융합데이터센터


근거중심한의약 DB

Home > 한의약융합데이터센터 > 근거중심한의약 DB
Title

Cost-effectiveness for acupuncture in seasonal allergic rhinitis: economic results of the ACUSAR trial.

Authors

Reinhold T, Roll S, Willich SN, Ortiz M, Witt CM, Brinkhaus B.

Journal

Ann Allergy Asthma Immunol.

Year

2013

Vol (Issue)

111(1)

Page

56-63. 

doi

10.1016/j.anai.2013.04.008. 

PMID

23806461

Url

http://www.ncbi.nlm.nih.gov/pubmed/23806461

MeSH

Acupuncture Therapy/economics*
Adolescent
Adult
Cost-Benefit Analysis
Female
Germany
Health Care Costs
Health Status*
Humans
Male
Middle Aged
Quality of Life
Quality-Adjusted Life Years
Rhinitis, Allergic, Seasonal/drug therapy
Rhinitis, Allergic, Seasonal/therapy*
Young Adult

Keywords

한글 키워드

KMCRIC
Summary & Commentary

KMCRIC 비평 보기 +

Korean Study

Abstract

BACKGROUND:
Allergic rhinitis (AR) is a frequent allergic disorder with a significant economic effect on health care costs and productivity.
OBJECTIVE:
To assess the cost-effectiveness of acupuncture for patients with seasonal AR (SAR) in Germany.
METHODS:
The present analysis was part of the Acupuncture in Seasonal Allergic Rhinitis (ACUSAR) trial, a 3-arm randomized, controlled, multicenter trial in patients with SAR, comparing acupuncture plus rescue medication (RM), penetrating sham acupuncture plus RM, and a control group receiving RM alone. Measures for health economic analyses were costs and health-related quality of life. Incremental cost-effectiveness ratio was calculated for different scenarios on the duration of acupuncture effects and was expressed as costs per quality-adjusted life-year gained. The study was conducted from society's and from a third-party payer's perspective.
RESULTS:
From 422 initially randomized patients, a total of 364 patients with complete data on costs and quality of life were included in the health economic evaluation. Patients receiving acupuncture or sham acupuncture caused higher costs than patients in the RM group. Patients in the acupuncture group gained significantly more quality-adjusted life-years compared with the RM group. Depending on different scenarios, the incremental cost-effectiveness ratio for acupuncture patients was between €31,241 (approximately US $38.569) and €118,889 (approximately US $146,777) from society's perspective and between €20,807 (approximately US $25,688) and €74,585 (approximately US $92.080) from a third-party payer's perspective.
CONCLUSION:
Acupuncture is an effective intervention that results in improved quality of life in patients with SAR. However, in times of limited resources for health care, acupuncture for AR may not be a cost-effective intervention.
TRIAL REGISTRATION:
clinicaltrials.gov Identifier: NCT00610584.

국문초록

Language

영어

첨부파일